Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,839 | -29,043 | -19,100 | -9,080 | -22,348 |
| Depreciation Amortization | -299 | -254 | -181 | -96 | -580 |
| Accounts receivable | -153 | N/A | -128 | -228 | N/A |
| Accounts payable and accrued liabilities | 507 | 1,055 | 1,975 | 1,149 | 439 |
| Other Working Capital | 1,467 | 3,168 | 3,308 | 281 | 6,453 |
| Other Operating Activity | 498 | -480 | -1,439 | -736 | 365 |
| Operating Cash Flow | $-34,819 | $-25,554 | $-15,565 | $-8,710 | $-15,671 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,381 | -799 | -643 | -238 | -1,174 |
| Purchase Sale Intangibles | N/A | -372 | -235 | N/A | -4,826 |
| Other Investing Activity | 0 | -372 | -235 | 0 | -4,826 |
| Investing Cash Flow | $-1,381 | $-1,171 | $-878 | $-238 | $-6,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4 | -4 | -3 | -2 | N/A |
| Common Stock Issued | 45,690 | 9 | N/A | N/A | 71,863 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -433 |
| Financing Cash Flow | $45,686 | $5 | $-3 | $-2 | $71,430 |
| Beginning Cash Position | 64,528 | 64,528 | 64,528 | 64,528 | 14,769 |
| End Cash Position | 74,014 | 37,808 | 48,082 | 55,578 | 64,528 |
| Net Cash Flow | $9,486 | $-26,720 | $-16,446 | $-8,950 | $49,759 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,819 | -25,554 | -15,565 | -8,710 | -15,671 |
| Capital Expenditure | -1,381 | -799 | -643 | -238 | -1,174 |
| Free Cash Flow | -36,200 | -26,353 | -16,208 | -8,948 | -16,845 |